| Literature DB >> 29085776 |
Alberto J Espay1, Thomas Maloney2, Jennifer Vannest2, Matthew M Norris3, James C Eliassen3, Erin Neefus4, Jane B Allendorfer5, Anthony E Lang6, Jerzy P Szaflarski5.
Abstract
BACKGROUND: Despite its high prevalence and associated disability, the neural correlates of emotion processing in patients with functional (psychogenic) tremor (FT), the most common functional movement disorder, remain poorly understood.Entities:
Keywords: AFNI, Analysis of Functional Neuroimages; CPT-END, continuous performance task with emotional and neutral distracters; Conversion disorder; EPI, echo-planar imaging; Emotion processing; FSL, FMRIB Software Library; FT, functional tremor; Functional movement disorders; Functional tremor; HAM-A, Hamilton Anxiety Rating Scale; HAM-D, Hamilton Depression Rating Scale; MDEFT, modified equilibrium Fourier transform; MINI, Mini International Neuropsychiatric Interview; Psychogenic tremor; fMRI; fMRI, functional magnetic resonance imaging
Mesh:
Year: 2017 PMID: 29085776 PMCID: PMC5655406 DOI: 10.1016/j.nicl.2017.10.020
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Fig. 1Regions of interest used in connectivity analysis based on the activation patterns from the intense-emotion task and subcortical atlas. The anatomical regions of interest included the anterior cingulate gyrus, posterior cingulate gyrus and left and right regions of the uncus/amygdala, thalamus, caudate, putamen, and subthalamic nuclei. The regions from the group activation of the task included regions in the left cerebral cortex, right frontal pole, right postcentral gyrus, left precuneus cortex and right superior frontal gyrus along with two regions in the left lateral occipital cortex, two regions in the left cingulate gyrus, three regions in the right lateral occipital cortex, and regions in the left and right middle frontal gyrus.
Clinical features of study subjects.
| Subject/sex | Age (years) | Affected body part | Duration (years) | HAM-A | HAM-D | MINI | Medications | |
|---|---|---|---|---|---|---|---|---|
| Functional tremor | 1 F | 52 | BUE, BLE | 18 | 15 | 17 | MDD (P) | Duloxetine, alprazolam, primidone, amitriptyline, propranolol |
| 2 F | 50 | BUE | 2 | 17 | 17 | None | Milnacipran | |
| 3 F | 46 | LUE, head | 11 | 8 | 15 | NGSP, OCD (C) | Clonazepam | |
| 4 F | 56 | BUE | 3 | 27 | 17 | None | Duloxetine, modafinil, methylphenidate, imipramine, lorazepam, gabapentin | |
| 5 M | 40 | LUE > RUE | 20 | 6 | 19 | None | Carbamazepine, citalopram | |
| 6 F | 64 | RUE | 11 | 0 | 5 | MDD (C) | None | |
| 7 F | 49 | BUE, BLE | 21 | 15 | 19 | MDD, PD-Ag, GSP, OCD, PTSD, GAD (C) | Risperidone, clonazepam, propranolol | |
| 8 F | 60 | BUE | 3 | 3 | 2 | None | Lorazepam, valproate, sertraline | |
| 9 F | 34 | BUE, head | 3 | 2 | 16 | PD-Ag, GSP, OCD, PTSD, Hypomania (C) | Duloxetine | |
| 10 F | 55 | BUE | 4 | 20 | 11 | Agoraphobia (C) | Duloxetine, trazodone, alprazolam | |
| 11 F | 63 | Head, trunk, BLE | 3.5 | 1 | 3 | None | None | |
| 12 F | 45 | BUE | 1 | 3 | 5 | None | None | |
| 13 F | 58 | RUE, stuttering | 2 | 28 | 20 | MDD, PD, PTSD, MDSP (C) | Citalopram, quetiapine, clonazepam, lamotrigine, sertraline | |
| 14 F | 38 | RUE, RLE, eye | 4 | 7 | 10 | None | Citalopram, diazepam, propranolol, topiramate | |
| 15 F | 38 | BUE, head | 4 | 28 | 26 | MDD, PD-Ag, PTSD, GAD (C) | Cyclobenzaprine, duloxetine | |
| 16 F | 38 | BUE | 1.2 | 3 | 3 | None | Clonazepam | |
| 17 F | 43 | BLE, stuttering | 6 | 46 | 43 | MDD, GAD, PD, PTSD (C) | Paroxetine | |
| 18 M | 27 | RUE | 1 | 0 | 0 | None | Amitriptyline | |
| 19 M | 44 | BLE > BUE, head | 3.5 | 24 | 18 | PD, PTSD (P) | Gabapentin, fluoxetine, clonazepam, baclofen | |
| 20 F | 66 | LUE, BLE | 1 | 22 | 11 | None | None | |
| 21 M | 65 | Head, RUE, LUE | 1.5 | 5 | 7 | None | None | |
| 22 F | 49 | BUE | 1 | 27 | 29 | MDD, PD-Ag, PTSD (C) | Clonazepam, diazepam, venlafaxine | |
| 23 F | 52 | BUE, BLE | 0.5 | 23 | 32 | MDD, GSP (C) | Valproate, gabapentin, alprazolam, baclofen | |
| 24 F | 75 | RUE, RLE | 1 | 13 | 10 | None | Escitalopram | |
| 25 F | 58 | Head, BUE | 1.5 | 5 | 9 | None | Primidone, propanolol, trazodone | |
| 26 F | 63 | RUE, RLE | 2.5 | 14 | 15 | PD-Ag, OCD (C) | None | |
| 27 F | 53 | Face, head, BUE, BLE | 1 | 32 | 23 | MDD, PD, GSP (C) alcohol dependence (P) | Clonazepam, desvenlafaxine, lamotrigine, lithium carbonate | |
| Essential tremor | 1 | 68 | BUE | 9 | 0 | 1 | None | Propranolol, hydrocodone, ropinirole |
| 2 | 46 | BUE | 30 | 0 | 0 | None | Propranolol, bupropion, duloxetine | |
| 3 | 56 | BUE | 40 | 0 | 0 | None | Atenolol | |
| 4 | 56 | RUE | 1.5 | 5 | 9 | None | Zolpidem, propranolol, amitriptyline | |
| 5 | 47 | BUE | 40 | 0 | 1 | None | Amitriptyline, primidone | |
| 6 | 64 | RUE > LUE | 53 | 0 | 0 | None | Primidone, gabapentin, propranolol, cyclobenzaprine | |
| 7 | 55 | BUE, neck | 35 | 23 | 20 | MDD, PD | Propranolol, quetiapine, lorazepam, lamotrigine, desvenlafaxine, flurazepam | |
| 8 | 64 | BUE | 20 | 0 | 0 | None | Unknown | |
| 9 | 61 | BUE | 49 | 7 | 3 | None | Citalopram, primidone | |
| 10 | 74 | BUE | 14 | 4 | 4 | None | Diazepam | |
| 11 | 75 | BUE, voice | 20 | 5 | 2 | None | Citalopram, clonazepam, primidone, topiramate | |
| 12 | 50 | LUE | 20 | 7 | 4 | GAD | Escitalopram, trazodone | |
| 13 | 61 | BUE | 21 | 0 | 0 | None | Propranolol | |
| 14 | 69 | BUE | 50 | 0 | 1 | None | Zolpidem | |
| 15 | 73 | BUE, head | 20 | 0 | 0 | None | Propranolol | |
| 16 | 68 | LUE, head | 45 | 0 | 0 | None | Unknown |
HAM-D: 17-item Hamilton Depression Rating Scale; HAM-A: 14-item Hamilton Anxiety Rating Scale; MINI: Mini International Neuropsychiatric Interview to screen for axis I DSM-IV and ICD-10 psychiatric disorders; Ag: agoraphobia; OCD: obsessive-compulsive disorder; GAD: generalized anxiety disorder; GSP: generalized social phobia; MDD: major depression; MDSP: Mood Disorder with psychotic features; NGSP: non-generalized social phobia; PD: panic disorder; PTSD: post-traumatic stress disorder. RUE: right upper extremity; LUE: left upper extremity; RLE: right lower extremity; LLE: left lower extremity; RH: right hand; LH: left hand; RF: right foot; LF: left foot; B, bilateral; (C): current; (P): past.
Fig. 2Differences in fMRI activation for the finger-tapping task. A region in the right cerebellum with increased activation in the FT group compared to ET during right tapping compared to rest. Images are shown at a threshold of Z > 2.3 and p < 0.05 corrected, after controlling for HAM-D.
Fig. 3Differences in fMRI activation for the basic-emotion task (sad greater than neutral faces). Above, paracingulate gyrus and left Heschl's gyrus showed greater activation in the FT group than HC. Below, right precentral gyrus showed reduced activation in the FT compared to ET. Images are shown at a threshold of Z > 2.3 and p < 0.05 corrected, controlling for HAM-D.
Summary of connectivity.
| Contrast | ROI 1 | ROI 2 | t value | p value | FDR p |
|---|---|---|---|---|---|
| FT > HC | L putamen | R thalamus | 3.566485696 | 0.000697516 | 0.034709915 |
| L putamen | L precuneus cortex | 3.620004807 | 0.000588311 | 0.034709915 | |
| L putamen | Post. cingulate G | 4.003263873 | 0.000167205 | 0.034709915 | |
| R middle frontal G | R postcentral G | 3.544564582 | 0.000747598 | 0.034709915 | |
| R occipital cortex | R occipital cortex 2 | 3.742310385 | 0.000396638 | 0.034709915 | |
| R putamen | L precuneus cortex | 3.410815902 | 0.001135415 | 0.043372047 | |
| L amygdala | L middle frontal G | 3.337452006 | 0.001422406 | 0.046228209 | |
| Ant. cingulate G | L middle frontal G | 3.262964607 | 0.001782948 | 0.048288185 | |
| Post. cingulate G | R putamen | 3.267808005 | 0.001757106 | 0.048288185 | |
| HC > FT | L putamen | R putamen | 3.392599168 | 0.001201072 | 0.043372047 |
| L putamen | R superior frontal G | 3.649168746 | 0.00053587 | 0.034709915 | |
| L caudate | R superior frontal G | 3.661756816 | 0.00051464 | 0.034709915 | |
| ET > FT | R thalamus | R superior frontal G | 4.940914954 | 6.04E-06 | 0.001964324 |
| FT > HC (HAM-D regressed) | L amygdala | L middle frontal G | 4.03383398 | 0.000152953 | 0.049709585 |
HC: healthy controls; FT: finger tapping; ET: essential tremor; G; gyrus; ROI: region of interest; FDR: false discovery rate.